School of Public Health Dean Shawn Gibbs has led national and international research, training and policy related to responses to highly infectious diseases.
Thirty-one percent of respondents to a Texas A&M-led survey said they don’t intend to be vaccinated against COVID-19.
In a newly published study, researchers call for clinical trials of an FDA-approved heart medication.
The unique interagency agreement between Texas A&M and the Brazos County Health District aims to contain COVID-19 transmission on campus.
The Food and Drug Administration has approved two human clinical trials for the drug.
Aggies are encouraged to visit the A.P. Beutel Health Center if they’re experiencing symptoms or have been in contact with someone who is sick.
The co-directors of the Texas A&M Center for Population Health and Aging say social distancing can exacerbate some health risks for seniors.
Sterilizing used face masks and gowns by exposing them to electron beams could help mitigate the shortage of personal protective equipment.
A Texas A&M advanced practice nurse answers common questions about cloth face coverings.
Information from the Office of the Provost about class scheduling and instruction.
She will work with health experts and key administrators to safely welcome the Texas A&M community back to campus in the fall.
Scientists expect to see preliminary results from pre-clinical trials before Oct. 1.
They say a bipartisan inquiry will be needed to learn from pandemic response failures.
